Updated recommendations on the use of hydroxychloroquine in dermatologic practice - 14/12/17
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Hydroxychloroquine has unique immunomodulatory properties and an attractive adverse effect profile. Over the past 10 years, research has led to significant updates in clinical recommendations concerning the optimal use of hydroxychloroquine and monitoring of patients taking it. We discuss updated recommendations concerning hydroxychloroquine daily dosing, retinopathy screening, serologic monitoring, use in smokers, use in pregnant women, and adverse effect risk and monitoring. This review can hopefully serve as an aid to dermatologists and help ensure they continue using hydroxychloroquine safely and effectively.
Le texte complet de cet article est disponible en PDF.Key words : adverse effects, hydroxychloroquine, lupus erythematosus, monitoring, recommendations, retinopathy screening, whole blood levels
Abbreviations used : ABW, AE, CLE, G6PD, HCQ, IBW, LE, SLE, RPE, WB-HCQ
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
Vol 76 - N° 6
P. 1176-1182 - juin 2017 Retour au numéro
Article précédent
- Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate
- Joanna Przybyszewska, Abraham Zlotogorski, Yuval Ramot
- The depth of inflammation in frontal fibrosing alopecia and lichen planopilaris: A potential distinguishing feature
- Denise Wong, Lynne J. Goldberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.